Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Malignant Lymphoma

  Free Subscription


17.11.2025

2 Am J Surg Pathol
1 Blood
1 BMC Cancer
1 Br J Dermatol
1 Eur J Haematol
1 Haematologica
1 J Clin Oncol
1 Leuk Lymphoma
4 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. FLAIFEL A, Alves de Castro JV, Gong S, Schafernak K, et al
    Pediatric-Type Follicular Lymphoma of the Conjunctiva: Shared Histologic and Molecular Features With the Nodal Counterpart.
    Am J Surg Pathol. 2025 Nov 13. doi: 10.1097/PAS.0000000000002484.
    PubMed         Abstract available

  2. PATWARDHAN PP, Al-Attar A, Aggarwal N, Bailey NG, et al
    The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas.
    Am J Surg Pathol. 2025;49:1258-1265.
    PubMed         Abstract available


    Blood

  3. HU S, Tang G
    Mantle cell lymphoma with KMT2A rearrangement.
    Blood. 2025;146:2491.
    PubMed        


    BMC Cancer

  4. NAKABIRI J, Agaba B, Naitala R, Najjuuko B, et al
    Time from symptom recognition to cancer diagnosis and factors linked to delayed diagnosis of hematological childhood cancers at a tertiary hospital in uganda: a mixed methods study.
    BMC Cancer. 2025;25:1756.
    PubMed         Abstract available


    Br J Dermatol

  5. LISLE TL, Weis-Banke SE, Ahmad SM, Holmstrom MO, et al
    Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma.
    Br J Dermatol. 2025 Nov 10:ljaf450. doi: 10.1093.
    PubMed         Abstract available


    Eur J Haematol

  6. CASERTA S, Martino EA, Vigna E, Bruzzese A, et al
    T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions.
    Eur J Haematol. 2025 Nov 9. doi: 10.1111/ejh.70063.
    PubMed         Abstract available


    Haematologica

  7. RINGELSTEIN-HARLEV S
    Old methods, lasting impact in relapsed/refractory primary mediastinal B-cell lymphoma.
    Haematologica. 2025 Nov 13. doi: 10.3324/haematol.2025.289153.
    PubMed         Abstract available


    J Clin Oncol

  8. DICKINSON MJ
    Antibody-Drug Conjugates and Bispecific Antibodies for Lymphoma: Partners of Convenience or a Perfect Match.
    J Clin Oncol. 2025 Nov 7:JCO2502200. doi: 10.1200/JCO-25-02200.
    PubMed        


    Leuk Lymphoma

  9. DADASHOVA A, Aliyeva G, Mamedov M, Melikova L, et al
    Homocysteine-driven oxidative stress in pediatric lymphoma: a cross-sectional study of metabolic and genetic modulators.
    Leuk Lymphoma. 2025 Nov 11:1-10. doi: 10.1080/10428194.2025.2586081.
    PubMed         Abstract available


    Leukemia

  10. WEI W, Song Z, Wang Y, Li S, et al
    The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphoma.
    Leukemia. 2025 Nov 12. doi: 10.1038/s41375-025-02809.
    PubMed         Abstract available

  11. SUTO K, Takei N, Yokoyama K, Chiba M, et al
    Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.
    Leukemia. 2025 Nov 10. doi: 10.1038/s41375-025-02811.
    PubMed        

  12. KURZ KS, Zamo A, Drewes C, Madej E, et al
    Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.
    Leukemia. 2025 Nov 7. doi: 10.1038/s41375-025-02794.
    PubMed         Abstract available

  13. MOIA R, Ragaini S, Cascione L, Rinaldi A, et al
    The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.
    Leukemia. 2025 Nov 7. doi: 10.1038/s41375-025-02795.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.